MediXall Group, Inc.
MDXL · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $51 | $74,665 | $109,414 | $83,380 |
| - Cash | $11 | $3 | $63 | $646 |
| + Debt | $3,830 | $2,821 | $316 | $213 |
| Enterprise Value | $3,870 | $77,482 | $109,666 | $82,948 |
| Revenue | $309 | $59 | $15 | $0 |
| % Growth | 422.1% | 295.3% | – | – |
| Gross Profit | $73 | -$3,139 | -$3,051 | -$2,530 |
| % Margin | 23.6% | -5,296.2% | -20,349.5% | – |
| EBITDA | -$3,882 | -$6,524 | -$6,123 | -$5,928 |
| % Margin | -1,254.6% | -11,006.9% | -40,835.9% | – |
| Net Income | -$4,563 | -$6,830 | -$6,035 | -$5,932 |
| % Margin | -1,474.8% | -11,524.6% | -40,245.8% | – |
| EPS Diluted | -0.037 | -0.061 | -0.058 | -0.066 |
| % Growth | 38.9% | -5.7% | 11.6% | – |
| Operating Cash Flow | -$1,230 | -$3,561 | -$4,685 | -$3,503 |
| Capital Expenditures | $0 | -$1 | -$13 | -$92 |
| Free Cash Flow | -$1,230 | -$3,562 | -$4,698 | -$3,595 |